Compare SANA & MAN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SANA | MAN |
|---|---|---|
| Founded | 2018 | 1948 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Professional Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.4B | 1.4B |
| IPO Year | 2021 | 1994 |
| Metric | SANA | MAN |
|---|---|---|
| Price | $3.12 | $29.38 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 5 | 6 |
| Target Price | $7.80 | ★ $35.67 |
| AVG Volume (30 Days) | ★ 3.6M | 788.1K |
| Earning Date | 05-07-2026 | 04-16-2026 |
| Dividend Yield | N/A | ★ 4.69% |
| EPS Growth | ★ 17.24 | N/A |
| EPS | N/A | ★ 0.05 |
| Revenue | N/A | ★ $17,957,100,000.00 |
| Revenue This Year | N/A | $5.12 |
| Revenue Next Year | N/A | $3.42 |
| P/E Ratio | ★ N/A | $576.80 |
| Revenue Growth | N/A | ★ 0.58 |
| 52 Week Low | $1.98 | $25.15 |
| 52 Week High | $6.55 | $47.34 |
| Indicator | SANA | MAN |
|---|---|---|
| Relative Strength Index (RSI) | 42.42 | 53.37 |
| Support Level | $3.03 | $28.29 |
| Resistance Level | $3.43 | $29.64 |
| Average True Range (ATR) | 0.20 | 1.49 |
| MACD | -0.03 | 0.02 |
| Stochastic Oscillator | 23.81 | 72.58 |
Sana Biotechnology Inc is a biotechnology company. The company develops engineered cells as medicines and therapies to treat diseases. It is engaged in developing cell engineering programs for across a broad array of therapeutic areas with unmet treatment needs, including oncology, diabetes, B-cell-mediated autoimmune, and central nervous system (CNS) disorders, among others. Its pipeline of product candidates is comprised of SC291, SC262, SC255, UP421 and others.
ManpowerGroup Inc provides workforce solutions and services, including recruitment and assessment, upskilling, reskilling, training and development, career management, outsourcing, and workforce consulting. The company leverages its trusted brands, industry knowledge, and AI-enabled assessments and offers an extensive portfolio of training and leadership development solutions. Its reportable segments are Staffing and Interim, Outcome-Based Solutions and Consulting, Permanent Recruitment, and Others, with Staffing and Interim generating the majority of revenue. It operates in the Americas, Southern Europe, Northern Europe, and APME. The company derives the maximum geographical revenue from the Southern European region.